Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
2.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
3.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
4.

Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder.

Christman AK, Fermo JD, Markowitz JS.

Pharmacotherapy. 2004 Aug;24(8):1020-36. Review.

PMID:
15338851
5.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

6.

Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.

Simpson D, Plosker GL.

Drugs. 2004;64(2):205-22. Review.

PMID:
14717619
7.

Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder.

Simpson D, Plosker GL.

CNS Drugs. 2004;18(6):397-401. Review.

PMID:
15089111
9.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
10.
12.

Atomoxetine.

Simpson D, Perry CM.

Paediatr Drugs. 2003;5(6):407-15; discussion 416-7. Review. Erratum in: Paediatr Drugs. 2003;5(10):661. Dosage error in article text.

PMID:
12765489
13.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
14.

Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder.

Kratochvil CJ, Vaughan BS, Harrington MJ, Burke WJ.

Expert Opin Pharmacother. 2003 Jul;4(7):1165-74. Review.

PMID:
12831341
15.

Safety profile of atomoxetine in the treatment of children and adolescents with ADHD.

Wernicke JF, Kratochvil CJ.

J Clin Psychiatry. 2002;63 Suppl 12:50-5. Review.

16.

Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder.

Caballero J, Nahata MC.

Clin Ther. 2003 Dec;25(12):3065-83. Review.

PMID:
14749146
17.

Dexmethylphenidate.

Keating GM, Figgitt DP.

Drugs. 2002;62(13):1899-904; discussion 1905-8. Review.

PMID:
12215063
18.

Atomoxetine treatment of attention-deficit/hyperactivity disorder.

Eiland LS, Guest AL.

Ann Pharmacother. 2004 Jan;38(1):86-90. Review.

PMID:
14742801
19.

Novel treatments for attention-deficit/hyperactivity disorder in children.

Spencer TJ, Biederman J, Wilens TE, Faraone SV.

J Clin Psychiatry. 2002;63 Suppl 12:16-22. Review.

20.

Extended-release methylphenidate (Ritalin LA).

Lyseng-Williamson KA, Keating GM.

Drugs. 2002;62(15):2251-9; discussion 2260-1. Review.

PMID:
12381228

Supplemental Content

Support Center